Symposium: AHA Council on Basic Cardiovascular Sciences

描述（由申请人提供）： 这是一个多年期会议资助7 R13 HL 078309研讨会的竞争性续期申请：美国心脏协会基础心血管科学理事会。更新涉及6-10年，07/01/09-06/30/14。 这项拨款支持什么已成为世界上主要的年度会议处理分子心血管生物学和疾病。它由美国心脏协会基础心血管科学理事会赞助，该协会是世界领先的心血管科学家组织。该会议的起源可以追溯到1991年，当时理事会发起了一个以“分子心脏病学”为重点的会议。在2002年会议成为年度活动之前，断断续续地举行了后续会议。2004年，美国心脏协会正式承认该会议是一个永久性的，经常性的科学会议，并开始提供R13资金。 科学内容代表了分子心血管科学和新领域的传统主题的故意混合。后者经常被心血管领域以外的专家讨论，包括在不同的时间应激途径，细胞凋亡，干细胞，功能基因组学，高通量化学筛选，microRNA等。 该会议现已连续7年定期举行，于夏季在西部各州的一个僻静地点举行，但距离一个主要机场不到90分钟。会议的步伐是雄心勃勃的，有助于科学的强度。2008年会议包括11场会议的51名发言者、1名主旨发言者、4名早期职业调查员决赛选手和187张海报。然而，重要的“互动时间”是以3次早餐、2次午餐、1次晚餐、6次咖啡休息和3次海报会议的形式提供的。2009年会议将于09年7月20日至09年7月23日在内华达州拉斯维加斯湖的丽思卡尔顿酒店举行，由杰弗里·莫尔肯廷、托马斯·福斯、赫尔穆特·德雷克斯勒和小室一诚组织。表观遗传学将是一个特色主题。 从NHLBI寻求的支持将占会议费用的7%，并将用于心血管外展奖（少数民族旅行奖）和新研究者旅行奖。 (End摘要）

DESCRIPTION (provided by applicant): This is a competing renewal application for a multi-year conference grant 7R13HL078309 Symposium: American Heart Association Council on Basic Cardiovascular Sciences. The renewal pertains to years 6-10, 07/01/09-06/30/14. This grant supports what has become the major annual meeting in the world dealing with molecular cardiovascular biology and disease. It is sponsored by the Council on Basic Cardiovascular Sciences of the American Heart Association, the world's leading organization of cardiovascular scientists. The origins of the conference date back to 1991 when the Council initiated a meeting focused on "molecular cardiology". Follow-up meetings were held sporadically before the conference became an annual event starting in 2002. In 2004, the American Heart Association formally recognized this conference as a permanent, recurring scientific meeting and R13 funding commenced. The scientific content represents is a deliberate mix of traditional topics in molecular cardiovascular science and novel areas. The latter, which are often discussed by experts outside of the cardiovascular field, have included at various times stress pathways, apoptosis, stem cells, functional genomics, high throughput chemical screens, microRNAs, and others. The meeting, which has now taken place regularly for 7 consecutive years, is held during the summer at a Western states location that is secluded but within 90 minutes of a major airport. The pace of the meeting is ambitious and contributes to the scientific intensity. The 2008 meeting included 51 speakers in 11 sessions, 1 keynote speaker, 4 early career investigator finalists, and 187 posters. Significant "interaction time" is provided, however, in the form of 3 breakfasts, 2 lunches, 1 dinner, 6 coffee breaks, and 3 poster sessions. The 2009 meeting will be 07/20/09-07/23/09 at the Ritz Carlton, in Lake Las Vegas, NV and organized by Jeffery Molkentin, Thomas Force, Helmut Drexler, and Issei Komuro. Epigenetics will be a featured topic. Support sought from NHLBI would constitute 7% of conference costs and would be used toward Cardiovascular Outreach Awards (minority travel awards) and New Investigator Travel Awards. (End of Abstract)